232 results
6-K
EX-99.1
SPRC
SciSparc Ltd
3 Jun 24
SciSparc Secures Strategic Advantage with Grant of European Patent
7:13am
of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. For example, SciSparc uses forward-looking statements when
POS AM
SPRC
SciSparc Ltd
2 May 24
Prospectus update (post-effective amendment)
5:17pm
in securities litigation or shareholder derivative litigation in connection with the Merger, and this could divert the attention of SciSparc and AutoMax … litigation or shareholder derivative litigation frequently follows the announcement of certain significant business transactions, such as the sale
20-F/A
2023 FY
SPRC
SciSparc Ltd
2 May 24
Annual report (foreign) (amended)
9:18am
, in connection with the aforementioned litigation, the shares of Evero Health Ltd. held by Capital Point are dormant and were forfeited by Evero
425
SPRC
SciSparc Ltd
12 Apr 24
Business combination disclosure
9:23am
the meaning of the Private Securities Litigation Reform Act. These forward-looking statements include, among other things, statements regarding the structure … Financial Statements
Shareholder Litigation
Certain Adjustments
CONDITIONS PRECEDENT TO OBLIGATIONS OF EACH PARTY
No Restraints
Shareholder Approval
6-K
EX-99.1
SPRC
SciSparc Ltd
11 Apr 24
Agreement and Plan of Merger
4:05pm
Litigation
Certain Adjustments
CONDITIONS PRECEDENT TO OBLIGATIONS OF EACH PARTY
No Restraints
Shareholder Approval
Court Approval
Tax Rulings … set forth in the Parent Budget, make any expenditures, incur any Liabilities, settle, discharge or satisfy any claims, litigation or obligations
6-K
EX-99.2
hrcqoft9vg
11 Apr 24
Agreement and Plan of Merger
4:05pm
6-K
iss jfp1vzgbg1
11 Apr 24
Agreement and Plan of Merger
4:05pm
6-K
EX-99.3
hr9zts8p0k9rzwi5rq5l
11 Apr 24
Agreement and Plan of Merger
4:05pm
S-8
fkhc aolxaemz3
1 Apr 24
Registration of securities for employees
5:11pm
6-K
EX-99.1
bcbxvb
27 Mar 24
SciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating Depression
9:18am
6-K
EX-99.1
04rwmbi32t a46o8wl5n
15 Mar 24
SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial
8:00am
6-K
hc8j5rb85971ao68s
13 Mar 24
Report of Foreign Private Issuer
9:06am
6-K
EX-99.1
yrm2c7 dsf3h6h5
8 Mar 24
SciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management Technology
9:00am
6-K
EX-99.3
mggxwfk4l166y0 cr
8 Mar 24
SciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management Technology
9:00am
6-K
EX-99.1
p8lr8
29 Feb 24
Report of Foreign Private Issuer
9:07am
F-1
w6yn9gkn9g
27 Feb 24
Registration statement (foreign)
4:15pm
6-K
EX-99.1
k3m esmmn61mqb
27 Feb 24
SciSparc-Clearmind Partnership Yields Three New International Patent Applications for MDMA, Ibogaine and Ketamine Compounds
8:35am
6-K
EX-99.1
ipz 68hbf30legawpe9g
20 Feb 24
SciSparc and Clearmind Continue to Strengthen International Patent Portfolio with Next Generation Classic Psychedelic-Based Compounds
4:27pm
6-K
EX-99.1
e77u8rle
29 Jan 24
SciSparc Announces Initiation of Patient Recruitment for its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder
4:00pm